Tymlos and Pollakiuria - a phase IV clinical study of FDA data

Summary:

Pollakiuria is reported as a side effect among people who take Tymlos (abaloparatide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin D3, and have Osteoporosis post-menopausal.

The phase IV clinical study analyzes which people have Pollakiuria when taking Tymlos. It is created by eHealthMe based on reports of 16,502 people who have side effects when taking Tymlos from the FDA, and is updated regularly.

What is Tymlos?

Tymlos has active ingredients of abaloparatide. eHealthMe is studying from 16,516 Tymlos users. Check the latest studies of Tymlos.

What is Pollakiuria?

Pollakiuria (abnormally frequent passage of relatively small quantities or urine) is found to be associated with 1,745 drugs and 1,693 conditions by eHealthMe. Check the latest studies of Pollakiuria.

On Jul, 26, 2026

16,502 people reported to have side effects when taking Tymlos.
Among them, 170 people (1.03%) have Pollakiuria.

Among these 170 people:

* Approximation only. Some reports may have incomplete information.

Do you take Tymlos and have Pollakiuria?

- Check whether Pollakiuria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tymlos:

Tymlos (16,516 reports)

Pollakiuria treatments and more:

Pollakiuria (53,752 reports)

How severe was Pollakiuria and when was it recovered:

Pollakiuria in Tymlos

Expand to all the drugs that have ingredients of abaloparatide:

Pollakiuria and drugs with ingredients of abaloparatide

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tymlos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pollakiuria:

Pollakiuria (1,745 drugs)

Browse all the conditions that are associated with Pollakiuria:

Pollakiuria (1,693 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abaloparatide (the active ingredients of Tymlos) and Tymlos (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.